In the last 3 years, Edmond de Rothschild Private Equity has acquired 1 company. It has also invested in 1 other.
Edmond de Rothschild Private Equity’s most common sectors for investment are life science (15%) and business services (12%). The Firm’s most common investment types include growth capital (39%) and buyout (lbo, mbo, mbi) (17%). In total, Edmond de Rothschild Private Equity has invested in 4 US states and 10 different countries.
In the last 3 years, Edmond de Rothschild Private Equity has exited 7 companies. The Firm’s most common exit type is trade sale (42%). Edmond de Rothschild Private Equity’s largest (disclosed) exit occurred in 2014 when it sold Sapiens Steering Brain Stimulation for $200M.
Join Mergr to view Edmond de Rothschild Private Equity’s full profile and discover more large private equity firms just like it.
Join Mergr to view the latest updates and news from Edmond de Rothschild Private Equity.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
